Your browser doesn't support javascript.
loading
Impact of adherence to individual quality-of-care indicators on the prognosis of bloodstream infection due to Staphylococcus aureus: a prospective observational multicentre cohort.
Escrihuela-Vidal, Francesc; Kaasch, Achim J; Von Cube, Maja; Rieg, Siegbert; Kern, Winfried V; Seifert, Harald; Song, Kyoung-Ho; Liao, Chun-Hsing; Tilley, Robert; Gott, Hannah; Scarborough, Matt; Gordon, Claire; Llewelyn, Martin J; Kuehl, Richard; Morata, Laura; Soriano, Alex; Edgeworth, Jonathan; De Gopegui, Enrique Ruiz; Nsutebu, Emmanuel; Cisneros, José Miguel; Fowler, Vance G; Thwaites, Guy; López-Contreras, Joaquín; Barlow, Gavin; Ternavasio-De La Vega, Hugo Guillermo; Rodríguez-Baño, Jesús; López-Cortés, Luis Eduardo.
Afiliación
  • Escrihuela-Vidal F; Department of Infectious Diseases, Hospital Universitari de Bellvitge, Institut d´Investigació Biomèdica de Bellvitge, University of Barcelona, Barcelona, Spain.
  • Kaasch AJ; Institute of Medical Microbiology and Hospital Hygiene, University Hospital, Faculty of Medicine, Otto-von-Guericke University Magdeburg, Germany.
  • Von Cube M; Institute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany.
  • Rieg S; Division of Infectious Diseases, Department of Medicine II, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Kern WV; Division of Infectious Diseases, Department of Medicine II, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Seifert H; Institute for Medical Microbiology, Immunology and Hygiene, Faculty of Medicine, University of Cologne, Cologne, Germany; German Center for Infection Research, partner site Bonn-Cologne, Germany.
  • Song KH; Division of Infectious Diseases, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, South Korea.
  • Liao CH; Infectious Diseases, Department of Internal Medicine, Far Eastern Memorial Hospital, Taipei City, Taiwan.
  • Tilley R; Department of Microbiology, University Hospitals Plymouth National Health Service Trust, Derriford Hospital, Plymouth, United Kingdom.
  • Gott H; Department of Research and Development, University Hospitals Plymouth National Health Service Trust, Derriford Hospital, Derriford Road, Plymouth, United Kingdom.
  • Scarborough M; Nuffield Department of Medicine, Oxford University Hospitals National Health Service Foundation Trust, Headington, Oxford, United Kingdom.
  • Gordon C; Nuffield Department of Medicine, Oxford University Hospitals National Health Service Foundation Trust, Headington, Oxford, United Kingdom.
  • Llewelyn MJ; Department of Microbiology and Infectious Diseases, Brighton and Sussex University Hospitals National Health Service Trust, Royal Sussex County Hospital, Eastern Road, Brighton, United Kingdom.
  • Kuehl R; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland.
  • Morata L; Service of Infectious Diseases, Hospital Clínic of Barcelona, Barcelona, Spain.
  • Soriano A; Service of Infectious Diseases, Hospital Clínic of Barcelona, Barcelona, Spain.
  • Edgeworth J; Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, Kings College London, Guy's and St. Thomas' Hospitals National Health Service Foundation Trust, St Thomas' Hospital, Westminster Bridge Road, London, United Kingdom.
  • De Gopegui ER; Servicio de Microbiología, Hospital Universitari Son Espases, Instituto de Investigación Sanitaria Illes Balears, Centro de Investigación Biomédica en Red en Enfermedades Infecciosas, Palma, Spain.
  • Nsutebu E; Tropical and Infectious Disease Unit, Royal Liverpool and Broadgreen University Teaching Hospital, Prescot Street, Liverpool, United Kingdom.
  • Cisneros JM; Unidad Clínica de Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospital Universitario Virgen del Rocío, Consejo Superior de Investigaciones Científicas, Universidad de Sevilla, Instituto de Biomedicina de Sevilla, Seville, Spain.
  • Fowler VG; Division of Infectious Diseases and International Health, Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
  • Thwaites G; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, United Kingdom.
  • López-Contreras J; Infectious Diseases Unit, Department of Internal Medicina Hospital de la Santa Creu i Sant Pau, Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, Universitat Autónoma de Barcelona, Barcelona, Spain.
  • Barlow G; Department of Infection, Hull and East Yorkshire Hospitals National Health Service Trust, Hull, United Kingdom.
  • Ternavasio-De La Vega HG; Department of Internal Medicine, University Hospital of Salamanca-Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain.
  • Rodríguez-Baño J; Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena/Consejo Superior de Investigaciones Científicas/Instituto de Biomedicina de Sevilla, Seville, Spain and Centro de Investigación Biomédica en Red en Enfermedades Infecciosas, Madrid, Spain; Department o
  • López-Cortés LE; Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena/Consejo Superior de Investigaciones Científicas/Instituto de Biomedicina de Sevilla, Seville, Spain and Centro de Investigación Biomédica en Red en Enfermedades Infecciosas, Madrid, Spain. Electronic a
Clin Microbiol Infect ; 29(4): 498-505, 2023 Apr.
Article en En | MEDLINE | ID: mdl-36283610
OBJECTIVES: To analyse the adherence and impact of quality-of-care indicators (QCIs) in the management of Staphylococcus aureus bloodstream infection in a prospective and multicentre cohort. METHODS: Analysis of the prospective, multicentre international S. Aureus Collaboration cohort of S. Aureus bloodstream infection cases observed between January 2013 and April 2015. Multivariable analysis was performed to evaluate the impact of adherence to QCIs on 90-day mortality. RESULTS: A total of 1784 cases were included. Overall, 90-day mortality was 29.9% and mean follow-up period was 118 days. Adherence was 67% (n = 1180/1762) for follow-up blood cultures, 31% (n = 416/1342) for early focus control, 77.6% (n = 546/704) for performance of echocardiography, 75.5% (n = 1348/1784) for adequacy of targeted antimicrobial therapy, 88.6% (n = 851/960) for adequacy of treatment duration in non-complicated bloodstream infections and 61.2% (n = 366/598) in complicated bloodstream infections. Full bundle adherence was 18.4% (n = 328/1784). After controlling for immortal time bias and potential confounders, focus control (adjusted hazard ratio = 0.76; 95% CI, 0.59-0.99; p 0.038) and adequate targeted antimicrobial therapy (adjusted hazard ratio = 0.75; 95% CI, 0.61-0.91; p 0.004) were associated with low 90-day mortality. DISCUSSION: Adherence to QCIs in S. Aureus bloodstream infection did not reach expected rates. Apart from the benefits of application as a bundle, focus control and adequate targeted therapy were independently associated with low mortality.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 4_TD Problema de salud: 4_sepsis Asunto principal: Infecciones Estafilocócicas / Bacteriemia / Sepsis Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Microbiol Infect Asunto de la revista: DOENCAS TRANSMISSIVEIS / MICROBIOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 4_TD Problema de salud: 4_sepsis Asunto principal: Infecciones Estafilocócicas / Bacteriemia / Sepsis Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Microbiol Infect Asunto de la revista: DOENCAS TRANSMISSIVEIS / MICROBIOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: España
...